Effect of Lenvatinib treatment on the cell cycle and microRNA profile in hepatocellular carcinoma cells
{{output}}
Lenvatinib is a tyrosine kinase receptor inhibitor used to treat unresectable hepatocellular carcinoma (HCC). In this study, we investigated the antitumor effects of Lenvatinib treatment on HCC cell lines. Proliferation was examined in four HCC cell lines (HuH... ...
